Solvay Pharmaceuticals announced today its decision to discontinue all R&D activities for its investigational compound SLV319. This compound, a selective cannabinoid type 1 antagonist, was currently ...
MARLBOROUGH, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro, Senior Technology Scientist at AstraZeneca, about his research, as well as the role of compound ...
The TGA is set to enforce a new wave of guidelines designed to regulate (and possibly cease) the on-site production of compound pharmaceuticals made to mimic popular medications such as Ozempic and ...
ST. LOUIS--(BUSINESS WIRE)--Three pharmacies have sued Express Scripts, Inc. for violations of federal regulations in a scheme to deny payments for compound pharmaceuticals. The suit alleges that ...
Dodgy companies peddling pricey compound pharmaceuticals have fleeced the Tricare program so severely this year, before tougher screening procedures took effect May 1, that they are largely to blame ...
CRANBURY, N.J., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics announced today its ...
Andover, MA - Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy TM Program candidate. Under this program, Formatech donates the ...
SAN FRANCISCO, April 10 /PRNewswire/ -- Antipodean Pharmaceuticals, Inc. announced today that it has completed its Phase 2 study of its lead compound, MitoQ(R) (mitoquinone) in liver disease. The ...
Though it still has strong prospects, this goal seems far too difficult to achieve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results